Literature DB >> 25275075

Short-term outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: preliminary analysis of a multicentre study.

Antonio Macrì1, Vincenzo Arcoraci2, Valerio Belgrano3, Marina Caldana4, Tommaso Cioppa5, Barbara Costantini6, Eugenio Cucinotta7, Franco De Cian3, Pierandrea De Iaco8, Giovanni De Manzoni4, Angelo Di Giorgio9, Francesco Fleres7, Francesca Muffatti10, Elena Orsenigo10, Antonio Daniele Pinna11, Franco Roviello5, Paolo Sammartino9, Giovanni Scambia6, Edoardo Saladino7.   

Abstract

AIM: To assess the incidence of morbidity and mortality of Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy. PATIENTS AND METHODS: A retrospective multicentric study was performed. Six hundred and eighty-three patients were recorded. Predictors of morbidity and mortality were evaluated with univariate and multivariate analysis.
RESULTS: In univariate analysis, older age, Eastern Cooperative Oncology Group score, a greater value of Peritoneal Cancer Index (PCI) and sub-optimal cytoreduction were correlated with higher mortality, while older age, presence of ascites, ovarian origin of carcinomatosis, closed technique, a greater value of PCI, longer operative time and sub-optimal cytoreduction were predictors of higher morbidity. In multivariate analysis, older age and a greater value of PCI were correlated with higher mortality; older age, ovarian origin of tumor, presence of ascites, closed technique and longer operative time were predictors of higher morbidity.
CONCLUSION: Careful patient selection has to be performed to improve clinical outcomes. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Cytoreductive surgery; HIPEC; hyperthermia; morbidity; mortality

Mesh:

Year:  2014        PMID: 25275075

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  Is it correct to perform omentoplasty to repair rectovaginal fistulas in oncological patients?

Authors:  Antonio Macrì
Journal:  Tech Coloproctol       Date:  2018-06-07       Impact factor: 3.781

2.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified?

Authors:  V López-López; P A Cascales-Campos; E Gil; J Arevalo; A Gonzalez; J Gil; F C Muñoz-Casares; J T Melero; P Barrios; R Morales; I Ramos; G Ortega; B Camps; L González-Bayón; P Bretcha-Boix; J Farré-Alegre; S González-Moreno; P Parrilla
Journal:  Clin Transl Oncol       Date:  2017-08-10       Impact factor: 3.405

3.  Indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in elderly patients with peritoneal malignancy.

Authors:  Toshiyuki Kitai; Kenya Yamanaka; Yuya Miyauchi; Masahiro Kawashima
Journal:  Int J Clin Oncol       Date:  2017-01-04       Impact factor: 3.402

Review 4.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality.

Authors:  Andrew D Newton; Edmund K Bartlett; Giorgos C Karakousis
Journal:  J Gastrointest Oncol       Date:  2016-02

5.  A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Joel M Baumgartner; Thomas G Kwong; Grace L Ma; Karen Messer; Kaitlyn J Kelly; Andrew M Lowy
Journal:  Ann Surg Oncol       Date:  2015-12-17       Impact factor: 5.344

6.  Efficacy and safety of ultrasound-guided continuous hyperthermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites: a midterm study of 36 patients.

Authors:  Yinbing Wu; Mingxin Pan; Shuzhong Cui; Mingchen Ba; Zulong Chen; Qiang Ruan
Journal:  Onco Targets Ther       Date:  2016-01-20       Impact factor: 4.147

7.  Technique of neuromonitoring during pelvic peritonectomy.

Authors:  Antonio Macrì; Giorgio Badessi; Carmelo Mazzeo; Marica Galati; Eugenio Cucinotta; Vincenzo Rizzo
Journal:  Pleura Peritoneum       Date:  2020-08-25

8.  Twelve-Year Single Center Experience Shows Safe Implementation of Developed Peritoneal Surface Malignancy Treatment Protocols for Gastrointestinal and Gynecological Primary Tumors.

Authors:  Philipp Horvath; Can Yurttas; Stefan Beckert; Alfred Königsrainer; Ingmar Königsrainer
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

9.  Predictors of morbidity and mortality in patients submitted to cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for ovarian carcinomatosis: a multicenter study.

Authors:  Antonio Macrì; Fabio Accarpio; Vincenzo Arcoraci; Francesco Casella; Franco De Cian; Pierandrea De Iaco; Elena Orsenigo; Franco Roviello; Giovanni Scambia; Edoardo Saladino; Marica Galati
Journal:  Pleura Peritoneum       Date:  2020-12-04

10.  Wernicke encephalopathy as rare complication of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Antonio Macrì; Francesco Fleres; Antonio Ieni; Maurizio Rossitto; Tommaso Mandolfino; Salvatore Micalizzi; Francesco Iaropoli; Carmelo Mazzeo; Massimo Trovato; Eugenio Cucinotta; Edoardo Saladino
Journal:  Int J Surg Case Rep       Date:  2015-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.